Related Articles
pSTAT5 and ERK exhibit different expression in myeloproliferative neoplasms
JAK2 V617F detected in two B‑cell chronic lymphocytic leukemia patients without coexisting Philadelphia chromosome‑negative myeloproliferative neoplasms: A report of two cases
Prevalence of the Janus kinase 2 V617F mutation in Philadelphia‑negative myeloproliferative neoplasms in a Portuguese population
Detection of JAK2 V617F mutation increases the diagnosis of myeloproliferative neoplasms
Effects of polymorphic DNA genes involved in BER and caspase pathways on the clinical outcome of myeloproliferative neoplasms under treatment with hydroxyurea